Clinical Presentation and Opportunistic Infections in HIV-1, HIV-2 and HIV-1/2 Dual Seropositive Patients in Guinea-Bissau
Overview
Authors
Affiliations
Background: Better understanding of HIV-2 infection is likely to affect the patient care in areas where HIV-2 is prevalent. In this study, we aimed to characterize the clinical presentations among HIV-1, HIV-2 and HIV-1/2 dual seropositive patients.
Methods: In a cross-sectional study, newly diagnosed HIV patients attending the HIV outpatient clinic at Hospital Nacional Simão Mendes in Guinea-Bissau were enrolled. Demographical and clinical data were collected and compared between HIV-1, HIV-2 and HIV-1/2 dual seropositive patients.
Results: A total of 169 patients (76% HIV-1, 17% HIV-2 and 6% HIV 1/2) were included in the study between 21 March 2012 and 14 December 2012. HIV-1 seropositive patients were younger than HIV-2 and HIV-1/2 seropositive patients, but no difference in sex was observed. Patients with HIV-1 and HIV-1/2 had a lower baseline CD4 cell count than HIV-2 seropositive patients (median CD4 cell count 185, 198 and 404 cells/μl, respectively (p value 0.001 and 0.05). HIV-1 seropositive patients had a lower BMI and a higher prevalence of weight loss, skin rash and productive cough than HIV-2 seropositive patients (p value 0.03, 0.002, 0.03 and 0.04). Only four cases (2%) of pulmonary tuberculosis (TB) were diagnosed. One patient (1/96, 1%) was tested positive for cryptococcal antigen.
Conclusion: HIV-1 and HIV-1/2 seropositive patients have lower CD4 cell counts than HIV-2 seropositive patients when diagnosed with HIV with only minor clinical and demographic differences among groups. Few patients were diagnosed with TB and cryptococcal disease was not found to be a major opportunistic infection among newly diagnosed HIV patients.
Puplampu P, Asafu-Adjaye O, Harrison M, Tetteh J, Ganu V Ann Glob Health. 2024; 90(1):13.
PMID: 38370863 PMC: 10870955. DOI: 10.5334/aogh.4149.
Diallo I, Ouedraogo S, Sawadogo A, Ouedraogo G, Diendere E, Zoungrana J J Int Assoc Provid AIDS Care. 2022; 21:23259582221143675.
PMID: 36474417 PMC: 9732798. DOI: 10.1177/23259582221143675.
Bhebhe A, Chongwe G, Moonga G Pan Afr Med J. 2022; 40:231.
PMID: 35178142 PMC: 8817188. DOI: 10.11604/pamj.2021.40.231.25149.
Alebel A, Demant D, Petrucka P, Sibbritt D BMC Infect Dis. 2021; 21(1):1.
PMID: 33390160 PMC: 7780691. DOI: 10.1186/s12879-020-05706-z.
HIV-2 as a model to identify a functional HIV cure.
Esbjornsson J, Jansson M, Jespersen S, Mansson F, Honge B, Lindman J AIDS Res Ther. 2019; 16(1):24.
PMID: 31484562 PMC: 6727498. DOI: 10.1186/s12981-019-0239-x.